Gary Lyons
Chairman bij TRAVERE THERAPEUTICS, INC.
Vermogen: 27 M $ op 31-03-2024
Profiel
Gary A. Lyons is een zakenman die GL Biomed heeft opgericht en aan het hoofd heeft gestaan van 5 verschillende bedrijven. De heer Lyons is voorzitter van Rigel Pharmaceuticals, Inc., voorzitter van Travere Therapeutics, Inc. en voorzitter van GL Biomed. De heer Lyons zit ook in de raad van bestuur van Neurocrine Biosciences, Inc. (voormalig Voorzitter, Chief Executive Officer & Bestuurder), Eledon Pharmaceuticals, Inc. en Brickell Biotech, Inc. Voordien bekleedde hij de functie van Uitvoerend Voorzitter van NeurogesX, Inc, Vice President-Business Development & Sales bij Genentech, Inc. en Sales Director-American Critical Care bij American Hospital Supply Corp. De heer Lyons behaalde een bachelorgraad aan de Universiteit van New Hampshire en een MBA aan de Kellogg School of Management.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
22-12-2023 | 193 697 ( 0.19% ) | 27 M $ | 31-03-2024 | |
17-05-2023 | 44 500 ( 0.06% ) | 343 095 $ | 31-03-2024 | |
26-05-2023 | 75 000 ( 0.04% ) | 111 000 $ | 31-03-2024 | |
01-05-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Gary Lyons
Bedrijven | Functie | Begin |
---|---|---|
NEUROCRINE BIOSCIENCES, INC. | Director/Board Member | 01-02-1993 |
RIGEL PHARMACEUTICALS, INC. | Director/Board Member | 01-10-2005 |
TRAVERE THERAPEUTICS, INC. | Chairman | 18-05-2016 |
Healthcare Royalty Management LLC
Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Director/Board Member | 01-01-2018 |
GL Biomed | Founder | 01-03-2008 |
Eerdere bekende functies van Gary Lyons
Bedrijven | Functie | Einde |
---|---|---|
FRESH TRACKS THERAPEUTICS, INC. | Director/Board Member | 02-10-2023 |
ELEDON PHARMACEUTICALS, INC. | Director/Board Member | 21-06-2023 |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Director/Board Member | 01-08-2019 |
PLUS THERAPEUTICS, INC. | Director/Board Member | 30-01-2019 |
░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Opleiding van Gary Lyons
University of New Hampshire | Undergraduate Degree |
Kellogg School of Management | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 8 |
---|---|
PONIARD PHARMACEUTICALS, INC. | Health Technology |
NEUROCRINE BIOSCIENCES, INC. | Health Technology |
RIGEL PHARMACEUTICALS, INC. | Health Technology |
HUMANIGEN, INC. | Health Technology |
PLUS THERAPEUTICS, INC. | Health Technology |
TRAVERE THERAPEUTICS, INC. | Health Technology |
ELEDON PHARMACEUTICALS, INC. | Health Technology |
FRESH TRACKS THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 10 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Health Technology |
IntraBiotics Pharmaceuticals, Inc.
IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | Health Technology |
Abbott Biotherapeutics Corp.
Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Abbott Biotherapeutics Corp. engages in the identification and development of oncology therapeutics. The firm's products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company was founded in 2008 and is headquartered in Redwood City, CA. | Health Technology |
American Hospital Supply Corp. | Health Technology |
NeurogesX, Inc.
NeurogesX, Inc. Pharmaceuticals: MajorHealth Technology NeurogesX, Inc. developed and commercialized novel pain management therapies. The company was founded by Wendye R. Robbins on May 28, 1998 and was headquartered in San Mateo, CA. | Health Technology |
PDL BioPharma, Inc.
PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
Healthcare Royalty Management LLC
Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Finance |
GL Biomed | |
Kalobios Pharmaceuticals, Inc. |